The use of chondroitin sulfate which binds CD44 overexpressed by tumor cells has recently been introduced [43]. Coupling of chondroitin sulfate to the surface of http://www.selleckchem.com/products/arq-197.html etoposide-loaded liposomes increased etoposide accumulation in breast cancer xenografts after

intravenous injection 40-fold compared to free drug and by 8-fold compared to untargeted liposomes. Presentation of lactose at the surface of doxorubicin-loaded PEGylated liposomes using a lactose-DOPE conjugate to target the asialoglycoprotein receptors overexpressed in hepatocellular carcinomas increased doxorubicin accumulation in tumors and resulted in tumor growth inhibition over untargeted Inhibitors,research,lifescience,medical doxorubicin-loaded liposomes [116]. Tan and coworkers introduced

ternary nucleic acid complexes, Liposome Polycation DNA (LPD) where nucleic acids are complexed by protamine before interaction Inhibitors,research,lifescience,medical with cationic liposomes to form a core nucleic acid complex surrounded by two lipid bilayers [155]. Sigma receptors are ion channel regulators overexpressed in several cancer types [156] Conjugation of the small molecular weight sigma receptor ligand anisamide, [157] to the distal end of ATPase PEG2000-DSPE allowed 70–80% luciferase silencing in an experimental lung metastasis model [113]. Moreover, parenteral injection of anisamide-armed LPD prepared with a combination of siRNA against Inhibitors,research,lifescience,medical the inhibitor of p53, MDM2 (Murine Double Minute 2), against the Cmyc oncogene and the other against the angiogenesis regulator, VEGF (Vascular Endothelial Growth Factor) were localized in tumors and allowed a 70–80% decrease in tumor load [68]. However, while the common Inhibitors,research,lifescience,medical sigma receptor agonist haloperidol and anisamide recognize sigma receptor type 1 and 2, only sigma receptor type 2 overexpression has been reported Inhibitors,research,lifescience,medical to be a prognostic indicator [158]. The latter has low expression in healthy tissues, suggesting a higher therapeutic index of sigma receptor 2 targeted therapies [158]. Indeed, binding of the sigma 2 receptor agonist SV119 Dacomitinib to its receptor induced cell death in vivo in a pancreatic

cancer model, and conjugation of SV119 to the surface of liposomes increased their uptake in vitro in cell lines including lung, breast, and prostate cancer carcinoma whereas no increased uptake in normal cells was reported [158]. 3. Biological Targets 3.1. Brain Tumor Targeting Brain tumors are a major concern for both primary brain and brain metastases from primary lung, melanoma, breast, and kidney cancers [159]. Therapy against brain cancers is challenging since the brain is largely isolated from the rest of the body by the blood brain barrier (BBB), a dense barrier of endothelial cells, pericytes, astrocytes, and extracellular matrix which limits molecular transport into the brain [160].